• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

First pharmacist-focused session coming to AHA Scientific Sessions 2011

News
Article

Over the past 3 decades, pharmacists have become integrated members of multidisciplinary teams. To recognize the value of the role of pharmacists in improving patient outcomes and safety in cardiac care, the American Heart Association (AHA) will offer pharmacists a session focused specifically on them at this year?s AHA Scientific Sessions in Orlando, Fla.

Over the past 3 decades, pharmacists have become integrated members of multidisciplinary teams. To recognize the value of the role of pharmacists in improving patient outcomes and safety in cardiac care, the American Heart Association (AHA) will offer pharmacists a session focused specifically on them at this year’s AHA Scientific Sessions in Orlando, Fla.

AHA  with the American College of Clinical Pharmacy’s (ACCP) Cardiology Practice and Research Network (Cardiology PRN), along with members of the AHA Clinical Pharmacology Committee will collaborate to target this session to the approximately 400 pharmacists who attend AHA annually.

The session will offer information on the specialized roles of pharmacists in the cardiovascular setting, demonstrate the impact of pharmacist interventions on healthcare, describe successful clinical programs, and provide insight into how the pharmacist can most effectively manage conditions such as hyperlipidemia, heart failure, hypertension, and anticoagulation, to improve patient outcomes and safety.

The session, called Improving Clinical Outcomes and Patient Safety Through Interventions by Clinical Pharmacists, will take place on Sunday, November 13, from 5:30 to 6:45 pm and will be co-moderated by Sheryl L. Chow, PharmD, BCPS and Robert L. Page, II, PharmD, MSPH, BCPS, FCCP, FAHA.

The program outline includes:

Cardiac Risk Reduction: Moving Beyond Statins
Heart Failure: More Than Titrating Doses
Hypertension: Getting Blood Pressure to Goal
Anticoagulation: Preventing Bleeding While Preventing Stroke
Q&A Discussion

For more information and to register, interested pharmacists can go to the Scientific Sessions on the American Heart Association website.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.